You are here

RSV

Is Novavax On The Fast Track To Profits?

Seeking Alpha

Mon, 07/8/13 - 10:58 am

Novavax Elevating To The Power Of 2

Seeking Alpha

Fri, 06/28/13 - 11:30 am

Gilead Sciences signs licensing deal with MicroDose for potential respiratory virus drug

Yahoo/AP

Wed, 04/20/11 - 12:06 pm

Gilead Sciences

MicroDose Therapeutx

PDL Settles MedImmune Dispute

Yahoo/Zacks.com

Fri, 02/18/11 - 03:17 pm

Abbott Laboratories

Deals to Be Done After AstraZeneca Setback

WSJ Online

Thu, 12/23/10 - 08:26 am

Cubist Pharmaceuticals

MicroDose Therapeutx

AstraZeneca Halts Drug, Takes Big Charge

TheStreet.com

Tue, 12/21/10 - 10:07 am

Red Signal for AstraZeneca Drug

Yahoo/Zacks.com

Mon, 09/6/10 - 10:01 am

Synagis' Special Status Under Health Care Reform

InVivo

Tue, 08/24/10 - 07:23 am

FDA Resets Motavizumab Decision to Aug. 27

TopWireNews

Sat, 06/26/10 - 10:50 am

AstraZeneca: FDA changes motavizumab review date

Marketwatch

Fri, 06/25/10 - 10:14 am

monoclonal antibodies

AstraZeneca Learns the FDA May Have Gotten Wise to Copy-Cat Drugs

BNET Pharma

Mon, 06/7/10 - 07:55 am

FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps

Seeking Alpha

Sun, 06/6/10 - 11:03 am

FDA panel rejects AZ's new RSV drug in key setback

Fierce Biotech

Thu, 06/3/10 - 10:07 am

Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'

Yahoo/PR NewsWire

Sat, 01/30/10 - 11:11 am

MedImmune responds to FDA on pediatric drug

Bizjournals.com

Mon, 12/28/09 - 04:42 am

MedImmune licenses RSV antibodies in $338M deal

Fierce Biotech

Tue, 12/1/09 - 10:25 am

Trellis Biosciences

Novavax gets grant for respiratory virus vaccine

Yahoo/AP

Tue, 10/13/09 - 10:21 am

Pages